Molly Hess, NP

NPI: 1578098943
Total Payments
$1,695
2024 Payments
$342.04
Companies
8
Transactions
16
Medicare Patients
750
Medicare Billing
$57,887

Payment Breakdown by Category

Food & Beverage$1,695 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $1,695 16 100.0%

Top Paying Companies

Company Total Records Latest Year
Lilly USA, LLC $466.41 4 $0 (2024)
Novo Nordisk Inc $268.10 3 $0 (2023)
GlaxoSmithKline, LLC. $246.18 2 $0 (2023)
Biohaven Pharmaceutical Holding Company Ltd. $229.73 2 $0 (2022)
Axsome Therapeutics, Inc. $220.86 2 $0 (2024)
ABBVIE INC. $102.50 1 $0 (2022)
Dynavax Technologies Corporation $99.99 1 $0 (2022)
AstraZeneca Pharmaceuticals LP $61.70 1 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $342.04 3 Axsome Therapeutics, Inc. ($220.86)
2023 $538.25 5 Lilly USA, LLC ($233.88)
2022 $668.57 6 Biohaven Pharmaceutical Holding Company Ltd. ($229.73)
2021 $146.61 2 Novo Nordisk Inc ($146.61)

All Payment Transactions

16 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
08/22/2024 Axsome Therapeutics, Inc. Auvelity (Drug) Food and Beverage In-kind items and services $113.52 General
Category: Psychology/Psychiatric
03/12/2024 Axsome Therapeutics, Inc. Auvelity (Drug) Food and Beverage In-kind items and services $107.34 General
Category: Psychology/Psychiatric
02/29/2024 Lilly USA, LLC MOUNJARO (Drug) Food and Beverage Cash or cash equivalent $121.18 General
Category: Diabetes
09/19/2023 GlaxoSmithKline, LLC. AREXVY (Drug) Food and Beverage In-kind items and services $121.18 General
Category: RESPIRATORY
06/01/2023 Lilly USA, LLC MOUNJARO (Drug) Food and Beverage Cash or cash equivalent $123.39 General
Category: Diabetes
03/23/2023 Lilly USA, LLC JARDIANCE (Drug) Food and Beverage Cash or cash equivalent $110.49 General
Category: Diabetes
02/21/2023 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Food and Beverage In-kind items and services $61.70 General
Category: Respiratory
02/16/2023 Novo Nordisk Inc Wegovy (Drug) Food and Beverage In-kind items and services $121.49 General
Category: Obesity
07/26/2022 Lilly USA, LLC MOUNJARO (Drug) Food and Beverage Cash or cash equivalent $111.35 General
Category: Diabetes
07/21/2022 GlaxoSmithKline, LLC. SHINGRIX (Biological) Food and Beverage In-kind items and services $125.00 General
Category: VACCINES
06/14/2022 Dynavax Technologies Corporation Heplisav-B (Drug) Food and Beverage In-kind items and services $99.99 General
Category: Hepatitis B Vaccine
04/27/2022 ABBVIE INC. UBRELVY (Drug) Food and Beverage In-kind items and services $102.50 General
Category: NEUROSCIENCE
03/03/2022 Biohaven Pharmaceutical Holding Company Ltd. NURTEC ODT (Drug) Food and Beverage In-kind items and services $124.43 General
Category: PRIMARY CARE
02/23/2022 Biohaven Pharmaceutical Holding Company Ltd. NURTEC ODT (Drug) Food and Beverage In-kind items and services $105.30 General
Category: PRIMARY CARE
12/15/2021 Novo Nordisk Inc Wegovy (Drug) Food and Beverage In-kind items and services $124.59 General
Category: Obesity
05/18/2021 Novo Nordisk Inc Saxenda (Drug) Food and Beverage In-kind items and services $22.02 General
Category: Obesity

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 8 236 306 $38,845 $19,102
2022 7 184 271 $35,251 $15,689
2021 5 136 201 $27,625 $10,836
2020 6 194 255 $33,245 $12,260
Total Patients
750
Total Services
1,033
Medicare Billing
$57,887
Procedure Codes
26

All Medicare Procedures & Services

26 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 100 162 $27,540 $10,710 38.9%
90677 Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use Office 2023 14 14 $4,270 $3,951 92.5%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 22 22 $3,630 $2,299 63.3%
90662 Influenza vaccine split virus, preservative free Office 2023 13 13 $1,095 $928.31 84.8%
36415 Insertion of needle into vein for collection of blood sample Office 2023 44 52 $1,040 $436.80 42.0%
G0008 Administration of influenza virus vaccine Office 2023 14 14 $350.00 $343.00 98.0%
G0009 Administration of pneumococcal vaccine Office 2023 14 14 $350.00 $343.00 98.0%
82044 Urine microalbumin (protein) analysis Office 2023 15 15 $570.00 $91.65 16.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 90 171 $29,070 $12,214 42.0%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2022 14 14 $2,310 $1,496 64.8%
90662 Influenza vaccine split virus, preservative free Office 2022 14 14 $1,115 $887.74 79.6%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 12 12 $1,440 $601.04 41.7%
G0008 Administration of influenza virus vaccine Office 2022 16 16 $400.00 $368.50 92.1%
36415 Insertion of needle into vein for collection of blood sample Office 2022 26 32 $640.00 $95.04 14.9%
81003 Automated urinalysis test Office 2022 12 12 $276.00 $26.63 9.6%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 78 140 $23,800 $8,913 37.4%
90662 Vaccine for influenza for injection into muscle, split virus, preservation free Office 2021 13 13 $975.00 $848.38 87.0%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 16 18 $2,160 $754.17 34.9%
G0008 Administration of influenza virus vaccine Office 2021 18 18 $450.00 $285.02 63.3%
36415 Insertion of needle into vein for collection of blood sample Office 2021 11 12 $240.00 $36.00 15.0%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 86 140 $23,800 $7,493 31.5%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 30 37 $4,440 $1,525 34.3%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2020 14 14 $2,310 $1,316 57.0%
90662 Vaccine for influenza for injection into muscle Office 2020 20 20 $1,400 $1,220 87.1%
G0008 Administration of influenza virus vaccine Office 2020 31 31 $775.00 $491.65 63.4%

About Molly Hess, NP

Molly Hess, NP is a Registered Nurse healthcare provider based in Anderson, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/24/2017. The National Provider Identifier (NPI) number assigned to this provider is 1578098943.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Molly Hess, NP has received a total of $1,695 in payments from pharmaceutical and medical device companies, with $342.04 received in 2024. These payments were reported across 16 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($1,695).

As a Medicare-enrolled provider, Hess has provided services to 750 Medicare beneficiaries, totaling 1,033 services with total Medicare billing of $57,887. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.

Practice Information

  • Specialty Registered Nurse
  • Other Specialties Family
  • Location Anderson, IN
  • Active Since 04/24/2017
  • Last Updated 06/29/2022
  • Taxonomy Code 163W00000X
  • Entity Type Individual
  • NPI Number 1578098943

Products in Payments

  • MOUNJARO (Drug) $355.92
  • Wegovy (Drug) $246.08
  • NURTEC ODT (Drug) $229.73
  • Auvelity (Drug) $220.86
  • SHINGRIX (Biological) $125.00
  • AREXVY (Drug) $121.18
  • JARDIANCE (Drug) $110.49
  • UBRELVY (Drug) $102.50
  • Heplisav-B (Drug) $99.99
  • BREZTRI (Drug) $61.70
  • Saxenda (Drug) $22.02

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Registered Nurse Doctors in Anderson